Skip to content
Company Analysis

CareDx, Inc. CDNA

A comprehensive view of key metrics, scores, and financial health for CareDx, Inc.

Overview of CareDx, Inc

CDNA NGM
Healthcare Diagnostics & Research Framework: Medical Devices & Diagnostics Small Cap
CareDx, Inc (CDNA), is a Small Cap company, in the Diagnostics & Research industry, last closed at $22.97, about 56.9% overvalued vs fair value, +23.6% 1Y return, ranked 549/1122 in sector.
Metrics Rev Growth 13.8% ROE -6.3% Gross Margin 67.0%
USD 22.97
-2.92%
(Delayed)
• Vol 90d: 62.9%
52-Week Range
Market Cap
$1.21B
Enterprise Value
$1.17B
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Fair
Health
Weak
Efficiency
Fair
Valuation
Weak
Growth
Fair
Profitability
Fair
Health
Weak
Efficiency
Fair
Valuation
Weak
Completeness: 82%
Confidence: 89%
Updated: Mar 8
Top Beats

Quick Facts

Website https://caredx.com
HQ Brisbane, CA
Employees 761
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Bear Base Bull
$9
$10
$11
Current: $22.97 -57% vs base

Engine Room Money Flow™

Small Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$379.8M
13.8%%
Gross Profit
$254.4M
13.5%%
Operating Income (GAAP)
$-21.0M
60.9%%
EBITDA
$-667.0K
98%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
67.0%
Excellent

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
2
Active Leaks
0/2
Improving
0
High Impact
2
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating CareDx, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
64
/100
Moderate
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Strong
77
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 85% Coverage
Trade-Off Triangle Visualization A ternary plot showing CDNA's balance between Growth (35.8%), Profitability (34.3%), and Safety (29.9%). Growth 36% Safety 30% Profitability 34%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

66th percentile vs peers
67
Key Signals
Rev Growth YoY 13.8% 65p EPS Growth YoY 1.26 94p Revenue CAGR 3Y 5.7% 46p
Strengths
  • EPS Growth YoY in top 20% of peers (1.26, 94th percentile)
  • Growth above peer median with strong metric coverage (75%)
  • Cash Flow to Debt Ratio in top 20% of peers (5.63, 95th percentile)
  • Consistently strong margins across 6 metrics
Risks

No significant risks identified for this axis.

Profitability

63th percentile vs peers
64
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

55th percentile vs peers
56
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for CareDx, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$9.89
- - -
-56.9% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000